Emerging Therapies for Neovascular Age-related Macular Degeneration: The Therapeutic Potential of Intravenous Immunoglobulin – Corrected Proof
Age-related macular degeneration (AMD) is a foremost cause of vision loss in aged individuals. We read with a great interest the recent article from Dr. Peter K Kaiser, who summarized the emerging therapies and ongoing clinical trials in the treatment of neovascular AMD. Because current antiangiogenic therapies require frequent injections, and that not all patients respond to these therapies, there is a need to identify additional therapies that could improve the treatment of neovascular AMD. The author also introduced preclinical and clinical trials on therapeutic intervention of AMD mostly targeted single molecules, such as nicotinic acetylcholine receptor, pigment epithelium-derived factor, (Read more...)